SGR-1505 - CAS 2661481-41-8

SGR-1505, an orally active MALT1 allosteric inhibitor, reduces MALT1 enzymatic activity and demonstrates anti-proliferative effects in both BTK inhibitor (BTKi) -sensitive and BTKi-resistant activated B cell-like diffuse large B cell lymphoma (ABC-DLBCL) cell lines. SGR-1505 is applicable for B-cell lymphoma research [1].

MALT

Immunology/Inflammation

2661481-41-8

C18H12ClF4N9O

481.79

C(F)(F)(F)[C@@]1(C)C2=C(N(C(NC=3C=C(Cl)C(=NC3)N4N=CC=N4)=O)C1)C=NC=5N2N=C(F)C5

-20°C

Ice Packs

Small Compound